Entera Bio (ENTX) Long-Term Deferred Tax (2021 - 2024)
Entera Bio's (ENTX) quarterly Long-Term Deferred Tax came in at $14000.0 in Q3 2024, down 6.67% YoY from $15000.0 in Q4 2023, and little changed on a QoQ basis from $14000.0 in Q2 2024.
Entera Bio (ENTX) Long-Term Deferred Tax (2021 - 2024) Analysis & Trends
Entera Bio (ENTX) has 4 years of Long-Term Deferred Tax data on file, last reported at $14000.0 in Q3 2024.
- Quarterly Long-Term Deferred Tax fell 6.67% year-over-year to $14000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 6.67% YoY) and the FY2023 annual result came in at $14000.0, down 67.44% from the prior year.
- Long-Term Deferred Tax steadied at $14000.0 in Q3 2024, from $14000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $280000.0 in Q2 2022 to a low of $14000.0 in Q4 2023.
- A 4-year average of $84416.7 and a median of $43000.0 in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax sank 84.64% — and 2024, when it declined 6.67%.
- Tracing ENTX's Long-Term Deferred Tax over 4 years: stood at $217000.0 in 2021, then slumped by 80.18% to $43000.0 in 2022, then slumped by 67.44% to $14000.0 in 2023, then changed by 0.0% to $14000.0 in 2024.
- The last three Long-Term Deferred Tax figures came in at $14000.0 (Q3 2024), $14000.0 (Q2 2024), and $14000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 280,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 217,000.00 |